Enantioselective Partitioning of Polychlorinated Biphenyls in a HepG2 Cell Culture System: Experimental and Modeling Results

20 April 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We investigated the partitioning of chiral PCBs (PCB 91, PCB 95, PCB 132, or PCB 136) in the human hepatoma HepG2 cell line and used a computational model for the in vitro to in vivo extrapolation (IVIVE) of PCB levels. HepG2 cells were incubated with PCBs for 72 h. PCB levels were quantified in cells, media, and cell culture dishes. PCBs were present in cell culture medium > cells > dishes, and displayed atropisomeric enrichment in cells and dishes. The free PCB concentration in media, estimated using polyparameters linear free energy relationships (PP-LFERs) and a composition-based model, was used to extrapolate from the nominal PCB concentration used in vitro to PCB tissue levels and vice versa. This approach allows for an IVIVE but does not account for the atropselective partitioning of chiral PCBs between medium and cells.

Keywords

2,2',3,4',6-Pentachlorobiphenyl
2,2',3,5',6-Pentachlorobiphenyl
2,2',3,3',4,6'-Hexachlorobiphenyl
2,2',3,3',6,6'-Hexachlorobiphenyl
Atropselective
Biological composition
Cell culture
Chiral
Composition-based model
Enantioselective
Free concentration
HepG2 cell
in vitro to in vivo extrapolation
IVIVE
Liver
Partitioning
PCB 91
PCB 95
PCB 132
PCB 136
Polychlorinated Biphenyl
Polyparameters linear free energy relationships
PP-LFER
sorptive capacity

Supplementary materials

Title
Description
Actions
Title
Data sheet D1
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.